Focus Stocks
Hospira Close to 50 Day Moving Average
Published on Monday, 09 January 2012 20:00 Written by Danny Miller
New York, January 9th (TradersHuddle.com) - Shares of Hospira, Inc. (NYSE:HSP) closed the trading day at $30.14 close to its 50 day moving average currently set at $30.12. Hospira's price action is just above this important support level translating into a trading opportunity.
Hospira, Inc. (NYSE:HSP) is a global specialty pharmaceutical and medication delivery company. The Company's product portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems.
Looking at peaks and troughs horizontal support and resistance levels, we can see current calculated support at $27.24 and calculated resistance at $31.52. These levels should also be evaluated by traders when planning their trades, as they provide an insight into the latest price action.
Traders wanting to establish a position on Hospira will be looking at the price action for evidence of buying near the 50 day moving average, and opening a position as close as possible to this important level. Also traders will be looking at the latest price action, via the stocks current range previously defined for insights of other key levels that might affect their upside or downside.
Related Articles
- I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
- Hospira Convenes Its 2012 Annual Meeting of Shareholders
- Hospira to Present at Upcoming Investor Conferences
- Hospira Reports First-Quarter 2012 Results
- Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
- Hospira Infusion Pumps Ranked Top Devices in New KLAS Smart Pumps 2012 Report
- Hospira Names John B. Elliot Senior Vice President of Operations
- Hospira to Host Conference Call for First-quarter 2012 Results
- Hospira's TheraDoc™ Clinical Surveillance System to Support Infection Prevention and Patient Safety Efforts at CHRISTUS Health
- Hospira Receives FDA Clearance for Symbiq™ 3.13 Infusion Pump
Related Partner Headlines
- Hospira up 9% on Strong Q4 Earnings - Benzinga
- UPDATE: Hospira Posts Upbeat Q4 Results, Issues Weak Forecast - Benzinga
- Hospira Stock Hits New 52-Week Low (HSP) - TheStreet.com
- Hospira Stock Hits New 52-Week Low (HSP) - TheStreet.com
- Hospira Hits 52-Week Low on Slashed Forecast - TheStreet.com
- Hospira Stock Gaps Down On Today's Open (HSP) - TheStreet.com
- Hospira Inc. (HSP): Today's Featured Health Care Loser - TheStreet.com
- Hospira Inc. Stock Downgraded (HSP) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Stocks To Watch For May 25 - Benzinga -
Top 4 Stocks In The Specialty Eateries Industry With The Highest Cash - Benzinga -
Top 4 Small-Cap Stocks In The Security Software & Services Industry With The Highest ROE - Benzinga -
Top 4 Small-Cap Stocks In The Health Care Plans Industry With The Highest Revenue - Benzinga -
Top 4 Small-Cap Stocks In The Heavy Construction Industry With The Lowest PEG Ratio - Benzinga -
Earnings Scheduled For May 25 - Benzinga -
Cramer's 'Mad Money' Recap: Big Government Not Protecting the Little Guys - TheStreet.com -
The Global Retrenchment Accelerates - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing Dialysis -
Score a Hit With FIFA 13 From Tesco Entertainment Online -
Syngenta settles atrazine litigation in the USA -
Atrazine Litigation Settled -
eMazzanti Attains Xerox Gold Partner Status -
USFS, BLM Hire Youth for Public Lands Conservation Jobs -
SCVBank Elects Scott K. Rushing as New Chairman -
Heritage Oaks Bancorp to Pay Trust Preferred Interest and Accumulated TARP Dividends









